Ion Beam Applications (IBA), a Belgian firm, landed FDA clearance for its latest superconducting accelerator for the Proteus ONE proton therapy. This will allow the company to deliver the Proteus ONE, a “compact” system, to U.S. shores.
The actual cyclotron weighs less than 50 metric tons and is less than 2.5 meters (8 feet) in diameter, which is quite small for an accelerator producing 230 MeV.
The patient gantry can rotate to any angle to target tumors from any direction best chosen by the physician and the design keeps the patient easily accessible to the medical staff.
Targeting is done thanks to a low-dose 3D digital X-ray imaging system that compares previously taken CT scans and aligns those against what it’s seeing in real time.
Product page: ProteusONE…